Recent research suggests that select athletes with cardiovascular abnormalities may be able to safely participate in competitive sports after shared decision-making with their clinicians about ...

New real-world data suggest that two out of every five patients with transthyretin amyloid cardiomyopathy treated with ...

Shared decision-making between clinicians and athletes of all ages who have cardiovascular abnormalities and want to participate in competitive sports is essential, according to a new joint scientific ...

Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complication due to its invasive nature. Researchers have now found a way to ...

Recent research suggests that select athletes with cardiovascular abnormalities may be able to safely participate in ...